SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : InvestRight - Short Term Trading St
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeffrey L. Henken who wrote (130)9/13/1998 10:44:00 AM
From: mike mulhearn  Read Replies (1) of 939
 
EXTI makes the liver dialysis machine to keep patiants alive until transplant. As far as pitfalls of disease being transmitted to humans from pig parts, they seemed to have solved the problem with transgenic pigs. And don't forget the articles you have referred to are 2-3 years old. We've come a long way.

This is a paragraph from article concerning transplant.

Nextran's John Logan says it will be at least two years before trials involving transplants into humans could begin.

"My suspicion is the first organ is probably going to be a kidney," he says, because "dialysis is an alternative, so if you lose the graft, you're not likely to lose the person. We're going to be very cautious. Our greatest danger is premature initiation of clinical trials. We want to be sure of a reasonable chance of success, and that the immunosuppressants we use are not going to kill the patient."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News